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ABSTRACT
The Rose of Insulin and Thyroid Hormones in
the Behavioral Effects of Estradiol in Rats
June, 1977
R. Thomas Gentry, B.A., B.S., Florida Atlantic
University, Ph.D., University of Massachusetts
Directed by: Dr. George N. Wade
In the first series of experiments (Section I) the
body weight and food intake-suppressing effects of
endogenous ovarian hormones and injected estradiol
benzoate (EB) were compared in streptozotocin-diabetic
and non-diabetic female rats. The absence of an effect
of diabetes indicated that the effects of estradiol
are not dependent on a change in the rate of insulin
secretion. Instead, EB-treatment altered the effect of
protamine zinc insulin on these same measures, consistent
with the hypothesis that estradiol affects body weight
and food intake via its effect on the physiological
sensitivity to insulin.
The experiments of Section II examined the effects
of insulin on EB plus progesterone (P)-induced sexual
receptivity and the neural uptake of H-estradrol m
ovariectomized female rats. The omission of insulin treat-
iv
merit in streptozotocin-diabetic animals for the first
24 hours of a 20-hour or 54- hour EB conditioning period
significantly reduced sexual receptivity. Twenty-four
hours of insulin withdrawal was also found to reduce the
cell nuclear concentration of tritium in the hypothalamus,
preoptic area and pituitary gland, two but not six hours
z
after an intravenous injection of H-estradiol.
In Section III the effects of hyper- and hypothyroidism
on sexual receptivity were investigated. Seventeen days
of thyroxine treatment was found to reduce the responsive-
ness of ovariectomized rats to exogenously administered
EB and P. This result was discussed in connection with the
known effects of thyroid hormones on estradiol metabolism.
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INTRODUCTION
The purpose of this series of experiments was to
extend our understanding of how estradiol influences be-
havior. Two general approaches were taken. In one
(Section I) the aim was to determine if a known effect
of estradiol, the suppression of body weight and food
intake, is mediated by an effect on another hormone
(insulin). In the other approach (Sections II and III)
the possibility was tested that non-steroid hormones
(insulin and thyroxine) influence the sensitivity of a
behavior to estradiol conditioning. In these cases the
behavior of interest was female sexual receptivity.
Both behaviors examined in these experiments are
believed to be mediated by direct estradiol action on
the brain, and there is reliable evidence to suggest
that the mode of estradiol action is similar to that in
non-neural reproductive tissues. There are hormone-
sensitive cells which react to the presence of the hormone
and which initiate the subsequent series of physiological
events leading to behavioral responses. Similar to the
process in. peripheral estrogen target tissue there is an
estrophilic protein in the cytosol of diencephalic brain
tissue which probably is a receptor. Once the estradiol-
receptor complex is formed, it is translocated to the cell
nucleus where it interacts with chromatin. (For review of
2this process see Jensen and DeSombre, 1973; Zigmond,
1975).
With the use of tritium-labelled estradiol it is
possible to quantify the amount of exogenously admin-
istered estradiol which is concentrated by neural
tissue. Thus the linkage between hormone and behavior
can be separated into two portions: the binding of
estradiol by brain tissues and the events subsequent
to neural uptake. Thin technique was used in Experiment
4- to determine the effect of insulin on the quantity of
H-estradiol uptake in homogenized neural tissue.
3SECTION I
THE ROLE OP INSULIN IN THE INFLUENCE OP
ESTRADIOL ON FOOD INTAKE AND BODY WEIGHT
Following the withdrawal of endogenous estradiol by
ovariectomy, female rats overeat and display an acceler-
ated rate of weight gain. After several weeks the hyper**
phagia subsides, and the rate of weight gain returns to
preoperative levels when body weight is about 20# above
that of gonadally intact animals (Gentry & Wade, 1976; Mook,
Kenney, Roberts, Nussbaum & Rodier, 1972; Tarttelin &
Gorski, 1973). Estradiol benzoate (EB) treatment to ovar-
iectomized rats reverses this pattern; there is an initial
period of hypophagia and weight loss for several weeks,
followed by a return to pretreatment levels of food intake
and body weight gain (Mook et al.
,
1972, Tarttelin & Gorski,
1966; Wade, 1975).
These observations have led several investigators to
conclude that the effect of estradiol on eating is second-
ary to the hormone's effect on body weight "set point"
(Mook, et al.
, 1972; Wade, 1972, 1976). The change in
food intake is viewed as a regulatory mechanism to bring
the animals actual weight in line with the altered "set
point" for body weight or adipose content.
In a recent review of the general physiology of
(
4-
hunger, Friedman and Strieker (1976) have concluded that
the notion of "set point" or "lipostat" is unnecessary if
the disposition of available caloric sources is taken into
account. A physiological condition, for example, which in-
duces abnormally high storage of nutrients into adipose
tissue simultaneously draws caloric sources away from
oxidative processes and thereby necessitates an increase
in food intake in order to maintain a constant supply of
nutrients for oxidation. Thus a mechanism for the effect
of estradiol on eating previously described as a change in
body weight "set point" may be that estradiol alters the
disposition of nutrients which then affects hunger by chang-
ing the availability of caloric sources.
One of the possible links between estradiol and the
control of nutrient storage and metabolism is insulin.
Insulin facilitates the removal of carbohydrates, amino
acids and fats from the blood and is effective in both
stimulating lipogenesis and inhibiting lipolysis. The in-
jection of long-acting insulin greatly increases food intake
and body weight (e.g., Mackay, Callaway & Barnes, 194-0;
Hoebel & Teitelbaum, 1966).
The influence of reproductive hormones on insulin
function is suggested by the manifestation of clinical
diabetes mellitus in susceptible women during pregnancy
(Williams & Porte, 1974- ) and by the induction of insulin
5resistance following the administration of estrogenic contra-
ceptive steroids (e.g., Pyorala, Pyorala & Lempinen, 1967 ;
Beck, 1969 ). Estrogens also have been found to alter plas-
ma levels of insulin (Bailey & Hatty, 1971 ) and the rate
of insulin secretion from pancreatic islets in vitro
(Costrini & Kalkhoff, 1971 ; Hager, Georg, Leitner & Beck,
1972 ).
Thus it is proposed that estradiol may affect food
intake and body weight by either altering the endogenous
secretion of insulin or by influencing the action of
insulin. This hypothesis is particularly appealing in light
of the facts that: high affinity estrogen receptors have
been identified in the same general diencephalic brain area
that is known to influence insulin secretion (Pfaff & Kein-
er, 1973 ; Woods & Porte, 1974-); and intracranial estradiol
implants into this same region effectively suppress eating
and body weight in ovariectomized rats (Beatty, O'Briant
& Vilberg, 1974- ; Jankowiak & Stern, 1974- ; Wade & Zucker,
1970 ).
The purpose of Section I was to investigate the role
of insulin function in the known effects of estradiol on
body weight and food intake.
6Experiment 1
Effect of Estradiol in Diabetic Female Rats
Experiment 1 was designed to evaluate the possibility
that the effects of estradiol on weight and food intake are
mediated by altering the rate of insulin secretion. If,
for example, estradiol lowers plasma insulin levels there
would be decreased lipogenesis and increased lipolysis.
This in turn would increase the internal availability
of nutrients which would reduce food intake until the
net adipose mobilization returned to normal. It is not
clear, however, whether estradiol alone inhibits or facil-
itates release of insulin is rats. Hager et al. (1972)
found that estradiol suppressed the in vitro release of in-
sulin, while Costrini and Kalkhoff (1971) fund an increase
under similar conditions.
To determine the contribution of changes in insulin
secretion, the effects of estradiol withdrawal and replace-
ment was compared in two groups of animals. One group of
animals was "normal" (i.e., capable of altering insulin
secretion in response to estradiol); the other group was
diabetic and had insulin levels artificially held constant.
It was reasoned that if changes in insulin secretion were
necessary, manipulations of estradiol would have signifi-
cantly attenuated effects on eating and weight in the ani-
mals with constant insulin levels.
7Method
General Method for Experiment 1. A total of 46
female rats (CD Strain, purchased from Charles River
Breeding Laboratories, Wilmington, MA) were used in these
experiments. Each animal was housed in an individual
cage in an air conditioned room with a 12:12 light :dark
cycle, and allowed ad libitum access to Purina Laboratory
Chow and tap water. Food intake was measured (to the near-
est 0.1 g) daily near the middle of the light period, and
body weights were recorded (to the nearest 1.0 g) every
third day.
To maintain constant levels of insulin, one group of
animals was first made diabetic with an intraperitoneal in-
jection of streptozotocin (Upjohn) in citrate buffer
(100 mg/kg body weight) and then given daily subcutaneous
injections of 2.4 units of U80 protamine zince insulin
(PZI, Lilly). (In previous, unpublished studies this dose
of PZI was found to maintain the weight gain of strepto-
zotocin-diabetic animals parallel to nondiabetic controls.)
The diabetic condition of streptozotocin-injected animals
was confirmed by testing for glycosuria with TesTape
(Lilly). Since diabetes can induce acyclicity in
female rats (Lawrence & Contopoulos, I960) it was also
necessary to confirm that the replacement doses of PZI
maintained normal cyclicity before the ovariectomies were
8performed. To do this vaginal smears were taken both
before and after streptozotocin treatment.
A second group of animals was not administered
streptozotocin and served as a "normal" control group
for all experiments.
Method for Part 1. Effect of ovariectomy
. Twelve
days after the administration of streptozotocin approximate-
ly two-thirds of the animals in each group ("diabetic"
and "normal") were bilaterally ovariectomized while the
remaining one-third received sham operations (laparotomies).
Ovariectomies were performed through a single midventral
incision while the animals were under methoxyflurane (Meto-
fane) anesthesia. The food intake and body weight of the
resulting four groups (diabetic-ovariectomized; diabetic-
sham; normal-ovariectomized; and normal-sham) were recorded
for 36 postoperative days.
Method for Part 2. Effect of estradiol benzoate .
The effect of estradiol benzoate (EB) on food intake and
body weight was evaluated in the ovariectomized animals
from Part 1. Thirty-six days after surgery the ovariec-
tomized animals of each group were distributed into two
groups (N = 6 or 7) approximately matched for body weight
and mean daily food intake. Two of these matched groups
(one diabetic and one normal) were then biven daily in-
jections of 5 pg EB dissolved in 0.05 cc sesame oil, while
9the other groups were biven daily injections of the
sesame oil vehicle alone. Thus there were four groups
of ovariectomized animals in this part of Experiment 1:
diabetic-EB; diabetic-Oil; normal-EB; and normal-Oil.
All injections were biven subcutaneously in the back of
the neck and were administered near the middle of the
12-hour light period each day. Food intake and body
weight were recorded for these animals for 15 days after
the initiation of EB injections.
Results of Experiment 1
Streptozotocin treatment . The administration of
streptozotocin to 25 animals resulted in the death of 2
animals and confirmed diabetes mellitus, as indicated
by positive glycosuria (TesTape), in the remaining 25 an-
imals. Of these 25 animals and the 21 animals not given
streptozotocin 5 animals in each group were eliminated
from the subsequent experiments because they either died
or showed excessive food spillage; resulting in groups
of N = 20 and N = 18 for the diabetic and the non-
diabetic groups respectively.
Streptozotocin administrati on was followed by
a drop in both food intake and body weight three days
after treatment (Figure 1). With daily injections
of 2.4 units PZI there was a rapid recovery of body
weight gain which was parallel to, but 5»0# below, non-
10
diabetic controls (Figure 1-A). At 12 days after strepto-
zotocin treatment the mean daily food intake of diabetic
animals was 15$ above non-diabetic controls. This
increased ad libitum eating was probably indicative of a
continued moderate state of diabetes despite PZI injections
sufficient to maintain normal weight gain.
Estrous cyclicity was maintained in all of the
animals given streptozotocin. Mean cycle length was
4.33 + 0.12 (SEM) days before treatment and 4.55 +
0.23 days after treatment.
Results of Fart 1. Effects of ovariectomy . Bilat-
eral ovariectomy was performed in 14 streptozotocin-
treated animals and 12 non-diabetic animals and sham
operations were performed in the remaining 6 animals of
each group providing intact control animals.
After an initial drop in weight three days after
surgery both diabetic and non-diabetic ovariectomized
animals showed increased rates of weight gain compared to
the sham-operated controls (Figure 2A). At the end of the
36-day observation period both ovariectomized groups
were about 17% heavier than their respective control
groups, t (18) = 3.828, £ < .01, for diabetics, and
t (16) = 3.666, £ < .01, for non-diabetics.
A comparison of the increase in body weight of the
two ovariectomized groups relative to their controls (i.e.,
11
weight of ovariectomized group minus the weight of
sham-operated group) is shown in Figure 2-B. The diabetic
animals showed an increase in weight after ovariectomy
very similar to normal, nondiabetic animals, and at 36
days after surgery both groups were exactly 49.8 g
heavier than their respective controls (Table 1).
The effects of ovariectomy on food intake are shown
in Figure 3-A. After a 15-day delay both diabetic and non-
diabetic animals demonstrated a period of hyperphagia.
The relative increase in food intake in diabetic animals
was generally similar to that of normal animals (Figure
3-B). A two-way analysis of variance of food intake over
the last 21 days of the observation period indicated that
there was no significant Treatment X Groups interaction,
F (1, 34) = 2.01?, 2 > 0 . 10 .
Results of Part 2. Effect of estradiol benzoate
treatment . Treatment with 5 jug EB per day significantly
suppressed body weight in both diabetic and non-diabetic
animals, paired t (6) = 2.976, £ < 0.05, and paired t (5)
= 5.088, £ < 0.01, respectively, while oil-injected cmtrols
continued to gain weight (Figure 4-A). A comparison of
either the relative body weight curve (Figure 4-B) or
the final body weight (two-way analysis of variance) indi-
cated that the suppression of weight following EB treatment
was equivalent in diabetic and normal animals (Treatment X
12
Groups interaction: F (1, 22) = 0.018, £ >0.50).
In nondiabetic animals EB treatment induced a
suppression in food intake which was maximum at 6 days after
the initiation of treatment (Figure 5-A). The diabetic
animals showed a significant initial suppression of food
intake, t (6) = 2.714, £ < .05, which was completely
reversed by Day 12 (Figure 5-B) . Fifteen days after
the beginning EB treatment the diabetic animals 'were eating
14 i 7# more than their controls. Although this increase
was not quite significant, t (12) = 2.022, 0.10 > £ > 0 . 05 ;
the change in food intake from baseline to Day 15 was
significantly greater in diabetic animals than in normal
animals, t (11) = 5.046, £ <£. 0.02 (Figure 5-B).
Discussion of Experiment 1
In this experiment the effects of ovariectomy and
replacement estrogen therapy on voluntary food intake and
body weight were determined in animals which were diabetic
and given constant daily injections of a long-acting insulin
and the results were compared to those of normal, non-
diabetic animals. In Part 1 it was found that ovariectomy
increased body weight and produced overeating in animals
with controlled levels of insulin in a manner very similar
to normal animals. In Part 2 it was found that EB-treatment
to diabetic ovariectomized animals was followed by a supp-
13
ression in body weight very similar to that of normal
animals. Food intake, however, was first suppressed then
increased by EB, unlike normal animals which showed some
undereating throughout the 15-day observation period.
Taken together, the results of Parts 1 and 2 in-
dicate that the effects of estradiol on body weight are
not dependent on changes in insulin secretion since
animals which presumably could not alter insulin
secretion still showed normal body weight changes in
response to estradiol withdrawal or replacement. In
general, food intake was also affected normally in
diabetic animals although the period of hypophagia follow-
ing EB-treatment was shorter than in normal animals.
The normal suppression of body weight (Figure 4) and
a relative increase in food intake (Figure 5) seen after
15 days of EB administration may indicate either: a) the
continued period of undereating is dependent on altered
(presumably lowered) plasma insulin levels; or b) estra-
diol induces a decrease in the effectiveness of insulin.
If the former is true it is difficult to explain why EB-
treatment would initially suppress eating. Antagonism of
insulin by estradiol is tentatively supported by the
combination of lowered body weight and relative hyperphagia
which is qualitatively similar to the effects of streptozo-
tocin (Figure 1).
Experiment 2
Effect of Estradiol On Insulin-Induced
Hyperphagia and Weight Gain
Although estrogens may not affect the secretion of
insulin it is possible that they modify the actions of
insulin. This possibility is consistent with the results
of Experiment 1, Part 2 which showed that food intake
of diabetic animals given constant amount of insulin
increased above normal animals after 15 days of EB
treatment. The reason that normal animals did not show
this secondary hyperphagia after EB administration may
be that they can compensate for the insulin-antagonism by
increasing their insulin secretion.
The hypothesis tested in Experiment 2 was that estra-
diol interacts to attenuate the effects of insulin relevant
to changes in body weight and food intake. To test
this possibility, the known stimulatory effects of long-
acting insulin on weight gain and food intake (e.g.
,
Mackay, et al.
.
194-0; Hoebel & Teitelbaum, 1966) were
compared in ovariectomized rats receiving either EB or
oil injections (Part 1).
Also of interest in this experiment was what happens
to food intake after the cessation of PZI injections. Hoe-
bel and Teitelbaum (1966) found that obese rats with ven-
tral medial hypothalamic lesions "regulated" their food
15
intake after a forced-feeding-induced further gain in
weight. That is, when the animals were returned to
ad libitum feeding they reduced their intake until they
returned to their previous weight. Since the PZI-
treatment in Part 1 increased the weight of ovariectomized
rats the analogous experiment for ovariectomy obesity is
reported here (Part 2).
Method
General method for Experiment 2. The 22 adult female
rats used in this experiment were born in the laboratory
and were derived (one generation) from CD-strain rats
(Charles River). Methods of housing, feeding and watering
these animals were the same as in Experiment 1. Pood
intake was recorded daily and body weights every fifth day.
Forty days before the initiation of PZI injections
all animals received bilateral ovariectomies as described
in Experiment 1. On the day of surgery the animals were
divided into two groups matched for body weight. Beginning
the day after ovariectomy and continuing through the
entire experiment one group (N = 11) was given daily
injections of 5 pg EB while the other group (N = 11)
received 0.05 cc of the sesame oil vehicle per day.
Method for Part 1. Effects of protamine zinc insulin
injections . Daily food intake was measured from three
days before the beginning of insulin injections through
16
the end of the experiment. After the three-day baseline
period, all animals received daily, subcutaneous infections
of 2.4 units of protamine zinc insulin (PZI, Lilly). On
the sixth day the dose of PZI was increased to 4.8 units
per day and this was continued for ten days.
Method for Part 2. Effects of protamine zinc insulin
cessation
.
The daily PZI infections were terminated while
the EB and oil infections were continued for ten more
days. The recording of daily food intake and the measure-
ment of body weight every fifth day were continued during
this period.
Results of Experiment 2
After the initiation of PZI infections two animals
that had been in the group receiving EB died. The data
of these animals was eliminated from all analyses leaving
N's of 9 and 11 for the EB and oil-infected groups
respectively.
Forty days after ovariectomy the mean weight of the
EB-treated group was 307*6 + 10.2 grams, and the weight
of the oil-treated animals was 15# higher (353.4- + 10.4
grams), t (18) = 2.890, £ 4. 0.01. The mean food intake
of the two groups was closely matched (Table 2) indicating
that the period of hyperphagia had subsided, t (18) = 0.085,
p > 0.10.
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Results of Part 1. Effects of protamine zinc insulin
injections. During the first five days of PZI-treatment
(2.4 units per day) the mean daily food intake of the oil-
treated animals was significantly greater than that of EB-
treated animals, t (18) = 2.596, £-< 0.05 (Figure 6-B,
Table 2). The relative increase in body weight (i.e.,
over baseline), however, did not differ between the two
groups, t (18) = 0.362, £> 0.10 (Figure 6-A).
Ten days after the initiation of the high dose of
PZI (4.8 units per day) the oil-injected group had gained
37# more weight, t (18) = 2.196, £^ 0 . 05 , and during this
period consumed significantly more food, t (18) = 2.771,
£ 0.02, than the EB- injected animals.
Results of Part 2. Effects of protamine zinc insulin
cessation
.
During the last ten days of the experiment
three animals became ill or died. The following analyses,
therefore, were based on the remaining nine EB-treated,
and oil-treated animals.
The cessation of PZI injections was followed by a
significant drop in body weight of both the oil-injected
and the EB-injected animals, paired t (8) = 3.843, £*£0.01,
and paired t (7) = 2.425, £< 0.05, respectively. The
means of the weights after 10 days without insulin inject-
ions were not significantly different from the weights at
18
the beginning of PZI infections, paired t (8) = 1.165,
£ >0.10, and paired t (7) = 0.089, £> 0.10 (Figure 7-A).
The magnitude of the weight decrease was not different in
the two groups, t ( 15 ) = 0.167* £ > 0.10.
The food intake of both groups showed a dramatic
initial decrease which was 25-30$ below that of baseline
(i.e., the mean daily food intake before insulin infections)
during tha first five days, paired t (8) = 6 . 051
,
£^ 0.01,
and paired t (7) = 4.801, £^0.01 (Figure 7-B). During
the second five-day period intake recovered to about 90$
of baseline but was still significantly below baseline,
paired t (8) = 4.660, £<C0.01, and paired t (7) = 2.511,
£< 0.05. The drop in food intake and partial recovery
was very similar in both groups of animals (Figure 7-B),
and the mean intake was not significantly different during
either the first, t ( 15 ) = 0.686, £ > 0.10, or the second,
t ( 15 ) = 1.447, £ > 0.10, five day period.
Discussion of Experiment 2
In this experiment the effects of a long-acting
insulin were determined in ovariectomized animals which
were receiving either estradiol benzoate or oil infections.
In Part 1 it was found that the oil-infected animals,
which were 15$ heavier at the onset of insulin infections,
increased their eating and weight gain more than the EB-
treated animals (Figure 6). These results are consistent
19
with the hypothesis that estradiol attenuates the effective-
ness of insulin on the metabolic events which mediate
insulin's effects on weight gain and hyperphagia.
In Part 2 of this experiment it was found that after
the cessation of insulin injections ovariectomized animals
lost weight and decreased their food intake in a pattern
very similar to that of estradiol-injected animals. These
findings indicate that the obesity induced by the with-
drawal of endogenous estrogens does not impair the ability
of these animals to make compensatory adjustments in
food intake and body weight following an experimental
further increase in weight.
General Discussion of Section I
In the introduction of Section I it was suggested that
estradiol may affect the food intake and body weight of
rats by interacting with insulin. Two possible mechanisms
of interaction were hypothesized: a) estradiol suppresses
the secretion of endogenous insulin or $ estradiol
attenuates the action of insulin on peripheral tissues.
Regardless of the particular mechanism, the suppression
of insulin's action on its target tissues (particularly
on adipose tissue) could theoretically be reflected in
the well-known effects of estradiol on eating and body
weight.
The general effect of insulin is to facilitate the
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clearance of plasma-born nutrients from the circulation.
Glucose, amino acids and fats are all affected by stimu-
lating their uptake into a variety of different tissues
including liver, muscle and adipose tissue. The effects
on adipose tissue is emphasized here because the gain in
weight after ovariectomy is thought to be primarily
the result of increased fat (Kennedy, 1969; Leshner &
Collier, 1973). Insulin promotes the storage of fats into
adipose tissue by several actions including: a) activating
lipoprotein lipase, which aids in the removal of trigly-
cerides from the circulation; b) making available abundant
glycerol phosphate (formed from glucose by glycolysis)
which esterifies with fatty acids to produce triglycerides;
and c) by inhibiting the hormone-sensitive lipase which
functions to mobilize triglycerides from adipocytes.
If estradiol interferes with these actions of in-
sulin on adipose tissue the result would be a temporary
increase in the rate of lipolysis relative to the rate of
lipogenesis. This effect would be self-limiting because
as the adipocytes decreased in size lipolysis would tend
to decrease (Gold.rick & McLoughlin, 1970; Hartman, Cohen,
Richane & Hsu, 1971). Thus there would be a temporary
change in body fat (and weight) which would then stabilize
at the point where the rates of lipolysis and lipogenesis
are once again approximately matched.
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During the period when adipose stores are diminishing
the nutrients which would normally be directed toward
adipose storage would instead accumulate at other sites.
Assuming this increase in available caloric sources would
be reflected in the physiological processes relevant to
the control of hunger (e.g., hepatic oxidative metabolism,
Friedman & Strieker, 1976), voluntary food intake would
be expected to: first decrease during the period of
decreasing adipose stores (i.e., during weight loss);
then return to normal when the balance between lipolysis
and lipogenesis is reestablished (i.e., when the rate of
weight gain returns to normal).
Thus the observations of transient changes in food
intake and the rate of weight gain and the permanent
changes in body weight and adipose content are consistent
with the proposition that estradiol interacts with in-
sulin function. Furthermore, emphasizing the effects of
estradiol on the systemic disposition of nutrients,
eliminates the necessity of using body weight "set point"
or lipostat to explain the same observations.
What remains to be established is the connection
between estradiol and insulin function. The two possible
mechanisms of interaction discussed here are: a) estradiol
suppression of the endogenous secretion of insulin; b)
estradiol attenuation of the action of insulin.
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The effect of estradiol on insulin secretion
The incubation of rat pancreatic islets with estra-
diol for two hours does not affect subsequent insulin
responses to glucose stimulation (Costrini 8c Kalkhoff,
1971). The in vivo administration of estradiol for at
least two weeks before the isolation of islets, however,
does affect insulin secretion but the results are in-
consistent. Costrini and Kalkhoff (1971) found that 5 jug
(but not 1.25 or 2.5 jug) estradiol benzoate per day for
three weeks significantly stimulated the In vitro insulin
release in response to glucose. Hager et al. (1972) on
the other hand, found that 7.5 jug of non-esterified
estradiol per day for approximately the same length of time
suppressed glucose stimulated insulin release measured
in vitro . They concluded that the discrepancy may be a
function of a difference in the incubation times of the
islets in the presence of glucose (in the Hager et al,
study the incubation period was 10 minutes and for the
Costrini and Kalkhoff study it was 90 minutes) and
suggested that of the two distinct phases of insulin
release to constant glucose stimulation (Curry, Bennett
& Grodsky, 1968), pretreatment with estradLoL may suppress
the first and augment the second.
The effect of estradiol on plasma insulin levels in
rats tends to agree with the findings of Costrini and
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Kalkhoff (1971), since Bailey and Matty (1972) found
that the administration of EB to ovariectomized animals
increased the magnitude of insulin secretion in response
to an intraperitoneal glucose challenge.
Because the effects of insulin increase food intake
and body weight (e.g.
,
Hoebel & Teitelbaum, 1966), it
would be expected that if changes in circulating insulin
levels mediate the effects of estradiol, insulin secretion
should be decreased by estradiol. Instead the evidence
just reviewed indicates that estradiol ultimately stimu-
lates the release of insulin.
In Experiment 1 the specific end-points of interest
(food intake and body weight) were examined in order to
determine if the experimental maintenance of constant
insulin levels could block the effects of estradiol. The
results were that holding insulin levels constant had no
effect on either ovariectomy or EB replacement therapy,
which indicated that a change in insulin plasma levels
is not necessary for the expression of estradiol's action
on eating and weight. This conclusion is independently
supported by noting previous reports which found that if
estradiol does affect insulin secretion, it does so in
the wrong direction to cause a decrease in body weight and
food intake.
The effect of estradiol on insulin action
Insulin resistance. As mentioned in the introduction
some women are susceptible to diabetes during pregnancy.
In "gestational diabetes" there is decreased glucose toler-
ance despite significant increases in plasma immunoassayable
insulin, and even "normal" pregnant women show hyperinsulin-
emia in the presence of normal plasma glucose levels
following a glucose challenge (Kalhoff, Schalch, Walker,
Beck, Kipnis & Daughaday, 1964 ). These effects are consid-
ered to be the result of peripheral resistance to insulin
action (Burt, 1956 ; Knopp, Ruder, Herrera & Freinkel,
1970) which induces a compensatory hyperinsulinemia to main-
tain normal carbohydrate tolerance (Costrini & Kalkhoff,
1971)
.
In a recent review Kalkhoff (1975) found that a
total of eleven investigations involving 227 women indi-
cated that the synthetic oral estrogens, Premarin,
diethylstilbesterol, ethinyl estradiol and mestranol, in-
duced a deterioration in glucose tolerance in a large
proportion (33/0 of the subjects; whereas a different set
of eleven investigations using parenterally administered
estrogens (principally estradiol and estriol) indicated
substantial improvements in glucose tolerance. Kalkhoff
(1975) concluded that the observed effects of estrogens
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on glucose tolerance may depend on the type of estrogen
(e.g., natural vs. synthetic) and/or the route of admin-
istration employed.
Further complicating the picture of insulin resistance
during treatment with estrogens is the possibility that
there is a biphasic time course of action. Lewis, Foglia
and Rodriguez (1950) found that estrogen treatment to
diabetic rats at first exaggerated hyperglycemia and then
reduced it. In normal women treated with ethinyl estra-
diol plus norethindrone
,
the biphasic effect appears to
operate in the opposite direction; there is a transient
improvement in glucose tolerance following short-term
administration (Clinch, Turnbull & Khosla, 1969) and
deteriorated glucose tolerance after long-term use (e.g.,
Spellacy, Buhi, Spellacy, Moses & Goldzieher, 1970;
Spellacy, Buhi, Birk & McCreary, 1971).
Effects of estrogens on lipid metabolism . In humans
the most commonly used estrogen components of oral contra-
ceptives (e.g., mestranol and ethinyl estradiol) have been
shown to induce marked (50-100^) increase in circulating
triglycerides and very low density lipoproteins (e.g.,
Hazzard, Spinger, Bagdade & Bierman, 1969; Gustafson &
Svanborg, 1972). Some authors have concluded that this
hyperlipidemia is primarily the result of increased
hepatic triglyceride production (e.g.. Beck, 1975) while
others have emphasized the decreased rate of lipid
clearance (e.g.
,
Haraosh & Hamosh, 1975)*
The clearance of lipids from the circulation by
a number of tissues, including adipose, mammary and
heart tissue, depends upon lipoprotein lipase which is
activated by insulin. A number of studies using human
and rat sugjects have demonstrated that both natural and
synthetic estrogens suppress adipose lipoprotein lipase
(Fabian, Stork, Kobilova & Sponarova, 1967; Hazzard et
al,
. 1969 ; Hamosh & Hamosh, 1975 )* It is, therefore,
probable that the hyperlipidemia is at least partially
caused by the inhibition of lipoprotein lipase.
Thus it is possible that the interaction between
insulin and estradiol demonstrated in Section I is at
least partially mediated by their effects on lipoprotein
lipase and is related to the known, effects of estrogens
on lipid metabolism. Regardless of the specific mode
of action the results of Experiment 2 suggest that the
effects of estradiol benzoate and insulin are not
merely additive but are interacting since the effects
of insulin on body weight and food intake were sig-
nificantly attenuated in the presence of the estrogen.
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SECTION II
THE EFFECT OF INSULIN ON ESTRADIOL-STIMULATED SEXUAL
RECEPTIVITY AND NEURAL UPTAKE OF 5H-ESTRADIOL
The nutritional state of animals is knovm to
affect neuroendocrine-ovarian function. Inanition due
to severe starvation is associated with a secondary anov-
ulatory syndrome in both rats and humans — possibly an
adaptive mechanism to limit population growth during peri-
ods of famine. Body weight or percentage of weight
as fat is also known to affect the onset of regular
estrous or menstrual cyclicity at puberty (e.g.
,
Frisch &
McArthur, 1974; Gentry, unpublished observations;
Kennedy, 1969).
Although the physiological mechanisms involved in
these effects are unknown they are perhaps analogous to
similar effects which accompany untreated diabetes
mellitus. Alloxan-diabetic rats, for example, are
characterized by either complete cessation of estrous
cycles (Lawrence & Contopoulos, I960) or irregular and
prolonged cycles (Levi & Weinberg, 1949). Phe effects of
both starvation and diabetes are readily reversible. In
the case of diabetes mellitus the administration of insu-
lin results in the resumption of normal estrous cyclicity
within four to five days (Lawrence & Contopoulos, I960);
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and in the case of starvation normal cyclicity is restored
upon refeeding and a gain in body weight (e.g.. Crisp &
Stonehill, 1971).
Diabetes may affect estradiol action in the brain
(and thus neuroendocrine-ovarian function) by altering the
rate of oxidative metabolism in hypothalamic and amygdalar
tissue (Schiaffini, Marin and Foglia, 1970). Another, and
not mutually exclusive mechanism, is indicated by the
results of Denari & Rosner (1972). These investigators
looked at the uptake of radioactivity in homogenized an-
terior hypothalamic, pituitary, uterine and vaginal tissue
dissected from ovariectomized rats one hour after the in
x
vivo injection of H-estradiol. They found a significant
reduction in uptake (expressed as disintegrations per
minute (DPM)/mg of wet tissue) in the hypothalamic and
pituitary tissues of alloxan-diabetic animals compared
with nondiabetic controls. They also found that insulin
replacement to diabetic animals reversed this effect.
Experiment 3
The Effect of Insulin on
Estradiol Stimulated Sexual Receptivity
Because the behavioral effects of estradiol are prob-
ably mediated by diencephalic uptake of the hormone (see
introduction) it is likely that the suppressed neur-
29
al concentration in diabetics would be reflected in a
reduced behavioral sensitivity. The purpose of the
following experiments was to determine if there is a
behavioral hyposensitivity to estradiol in diabetic
animals and also to confirm the findings of Denari and
Rosner ( 1972 ).
Method
General Method for Experiment 3. All animals
(female rats of the CD strain purchased from Charles
River Breeding Laboratories) were first ovariectomized and
then made diabetic with an intraperitoneal injection of
streptozotocin (100 jug/kg body weight). Each animal was
given daily injections of 3 units Lente insulin (Lilly)
—
a dose which maintained steady body weight. Comparisons
between "diabetics" and "nondiabetics" were actually com-
parisons between animals that had their insulin injections
omitted for one or two days and animals that had uninter-
upted daily injections of insulin. In the behavioral
experiments this procedure allox^ed the comparison of the
same animal under both "diabetic" and "nondiabetic" condi-
tions.
All animals were housed in individual cages under a
12:12 light: dark cycle and were given ad libitum access
to Purina Laboratory Chow and tap water.
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Sexual receptivity was determined by scoring the
quality of the lordosis to each mount by a male rat as
0, 1, 2 or 3, where 0 refers to no lordosis and 3
represents a maximal response (Powers & Valenstein, 1972).
The mean score in response to ten mounts represented the
animal's "mean lordosis rating" (MLR). Behavioral test-
ing was done under dim red light illumination in a circular
"arena" approximately six hours after the beginning of
darkness. Testing sessions were separated by a minimum
of six days and a maximum of eight days.
For all behavior paradigms 1 mg progesterone was
injected subcutaneously six hours before testing and
wither 2 or 4 /ig EB/kg body weight was injected either
54 or 30 hours before testing. The body weight used to
calculate the EB dosage was the last weight recorded before
the omission of an insulin injection. At the time of the
EB injection all animals in the "diabetic" condition were
checked for glycosuria with TesTape. The data for any
animals which were not glycosuric were not used in the
statistical analysis.
Method for Part 1. Fifty-four hour estradiol benzoate
condit ioning
«
All animals were tested under both of the
following conditions. In the "diabetic" condition, the
insulin injection which was normally given near lights-
out 54 hours before behavioral testing was omitted and
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either 2 or 4 jjg EB/kg body weight was administered at this
time. The insulin injections on the day of testing and
the day between EB injection and testing were given as per
normal schedule. In the "nondiabetic" condition, EB was
given 54- hours before testing and the insulin injection
was not omitted on that day. The behavioral testing was
done "blind", and the order of conditions was counter-
balanced so that on any one testing day, half of the ani-
mals were in each condition.
Method for Part 2. Thirty-hour estradiol benzoate
conditioning. Again each animal was tested under both
a "diabetic" and a "nondiabetic" condition in counterbalance
order. This time the delay between EB injection and
testing was 30 hours and in the "diabetic" condition the
insulin injection was omitted on the day before be-
havioral testing. Because the MLR was found to be too
low to show any suppression with 2 ^g EB/kg, only the 4- jig/
kg dose was used in Part 2.
Method for Part 3. Control. It is unlikely that
animals in the "diabetic" condition were sick during the
time of testing because they had received one or two insulin
injections after the day of insulin omission. But to test
for the possibility that a general malaise could explain
suppressed sexual receptivity in the "diabetic" condition
some animals were tested on the same day that the insulin
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injection is omitted. In this case EB injections were
given 50 hours before behavioral testing and the insulin
injection scheduled for 6 hours before testing was omitted.
Again the same animals were tested in this "diabetic" con-
dition and in a "nondiabetic" condition in which there was
no insulin injection omission. The nonparametric Sign Test
was used to evaluate changes in MLR and considered sig-
nificant if p< 0.05, two-tailed (Siegel, 1956).
Results of Experiment 3
Results of Part 1. Fifty-four hour estradiol ben-
zoate conditioning. The results of Part 1 are shown at
the top of Figure 8. With the low dose of EB (2 pg/kg)
the mean lordosis rating for the nondiabetic condition
was 0.49 + 0.24 (SET") and the MLR for the diabetic con-
dition was not significantly different at 0.44 + 0.22,
Sign Test (N = 6, x = 2), £ > 0.30.
With the high dose of EB (4 pg/kg), however, there
was a greater than 25$ decrease in MLR when animals were
in the diabetic condition. Sign Test (N = 11, x = 2)
2 0.05. The mean lordosis rating was 2.29 + 0.09 for
the nondiabetic condition, and 1.66 + 0.26 for the diabetic
condition.
Results of Part 2. Thirty hour estradiol benzoate
conditioning. The results of Part 2 are shown in the
middle of Figure 8. The MLR for animals in the nondia-
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betic condition was 1.97 + 0 . 29
,
and was 0.79 + 0.30 for
animals in the diabetic condition. This difference was
statistically significant. Sign Test (N = 14, x = 2),
£ < 0 . 05 .
Results of Part 5« Control. The results of Part
3 are shown on the bottom of Figure 8. The MLR for animals
tested on the day of insulin injection omission (1.90 +
0 . 51 ) was not significantly different from the test
conducted after no insulin injection omissions (2.05 +
0.24), Sign Test (N = 11, x = 6), £ > 0.50. All of the
animals used in this analysis were glycosuric just before
behavioral testing in the diabetic condition.
Discussion of Experiment 3
The results of Part 1 indicated that the omission of
a single daily dose of Lente insulin on the day of EB in-
jection significantly suppressed sexual receptivity if the
EB dose was sufficient to avoid a "floor" effect. The
reason animals in the diabetic condition showed no suppress-
ion when given 2 /jg EB/kg was probably that the MLR even
in the nondiabetic condition was so low (0.49) that there
was little room for a further decrease. More than half
of the animals tested with the low dose of EB showed MLR's
of 0.0 under both conditions and of the six animals which
did show some receptivity, four showed a suppression in
the diabetic condition.
35
Because estradiol requires at least 17 hours to
condition receptivity (Green, Luttke & Whalen, 1970) and
continues to act to facilitate receptivity for more than
24- hours it was thought that the insulin infection which
came 24- hours after the EB injection may have reversed some
of the suppression of receptivity in the diabetic condition.
For this reason the 30-hour EB conditioning period was
tried in Part 2.
The results of Part 2 also indicated that the animals
conditioned with EB in the absence of insulin were less
receptive than when conditioned in the nondiabetic
state. Analysis of the combined data of Parts 1 and 2
revealed a highly significant effect of insulin withdrawal,
Sign Test (N = 25, x = 4-) , p < 0.0005. Although the effect
appeared greater in the 30-hour paradigm (Figure 8) this
observation could not be statistically confirmed or
rejected because the MLR is an ordinal rather than an
interval scale.
The results of the control experiment (Part 3) suggest
that the suppression of receptivity observed in Parts 1
and 2 was not the result of illness, since even when
tested while glycosuric, these animals showed normal
levels of receptivity.
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Experiment 4
Uptake of ^H-Estradiol
in Diabetic Ovariectomized Rats
The results of Experiment 3 indicated that the stim-
ulation of sexual receptivity by estradiol benzoate was
significantly attenuated if there was an absence of insu-
lin during the first 24- hours of the conditioning period.
Denari and Rosner (1972) had found that alloxan-dia-
betic, ovariectomized rats showed a decrease in uptake of
^H-estradiol into NaOH-digested hypothalamic and anterior
pituitary tissue. They also showed that the uptake into
other tissues (vagina, uterus and diaphragm) was not sig-
nificantly affected by diabetes. Because they did not
examine cell nuclear uptake, there was no information
available on whether there is an affect of diabetes on the
translocation of estradiol into the nuclei of target tiss-
ues.
The purpose of Experiment 4 was to reexamine the up-
take in the whole homogenate of neural and hypophyseal
tissue and to determine if there was any deficit in cell
nuclear uptake. In addition to pituitary and hypothalamus,
uptake was also measured in an area just anterior to hypo-
thalamus including the preoptic area (which also shows a
great deal of specific uptake, e.g., Pfaff & Keiner,
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1973) and in the cerebral cortex, which shows relatively
little specific uptake.
Method
A total of 27 CD strain female rats were purchased
from Charles River Breeding Laboratories and used in this
experiment. Each animal was ovariectomized and made
diabetic with streptozotocin at least one week before use
(procedures were the same as in Experiment 1). As in
Experiment 3 all animals were diabetic and the "diabetic"
and "nondiabetic" conditions were differentiated by the
omission of insulin injections before the in vivo injection
z
of H-estradiol and sacrifice.
Uptake Procedure. ^H-estradiol (specific activity
91.3 Ci/mole; New England Nuclear, Boston, MA) was injected
intravenously in 25$ ethanol. At two (Part l) or six
(Part 2) hours after injection each animal was anesthetized
with sodium pentobarbital and a blood sample collected by
cardiac puncture into a heparinized syringe. Rats were
killed by perfusion with 0.9# saline and the brain removed
and disected to sample: cerebral cortex (approximately
150 mg wet weight); preoptic area (50 mg); and hypothalamus
(60 mg). The remaining brain portions were discarded.
The whole pituitary gland was also taken.
Each tissue was separately homogenized in a glass
homogenizer with a Teflon pestle at 4°C according to the
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method of McEwen and Zigraond (1972). Prom this sample 200
^1 of "whole homogenate" was taken. The remainder of the
sample (approximately 1.8 ml) was used to isolate the
cell nuclear fraction.
After isolation of the "nuclear pellet" (McEwen &
Zigmond, 1972) radioactivity was extracted from the whole
homogenate and nuclear pellet fractions three times with
A ml of toluene scintillation cocktail (5.0 g 2,5-diphenyl-
exazole and 0.05 g 1,4—bis-(2-(5-phenyloxazolyl))-benzene
per liter of scintillation grade toluene). Protein was
precipitated with ethanol and measured by the method of
Lowry, Rosebrough, Farr and Randall (1951). Blood samples
were centrifuged and a 0.1 ml sample of plasma was taken
and added directly to scintillation vials containing 12 ml
of the scintillation cocktail.
Radioactivity was counted in a Packard Instruments
Company Tri-Carb liquid scintillation spectrometer at an
efficiency of approximately 50$. Radioactivity levels were
expressed as disintegrations per minute (DPM)/rog protein
taking into account the correction for quenching in each
sample.
Uptake schedule. Pairs of animals, one "diabetic",
one "nondiabetic" were injected with ^H-estradiol 20 min-
utes apart with 90 minutes between the first animals of
each pair. Pour or six animals were sacrificed in one
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3day, and the first H-estradiol injection was given approx-
imately 2 to 4 hours after the onset of the dark cycle.
Insulin injection schedule. For animals in the "non-
diabetic" condition all insulin injections were given
according to the normal schedule, i.e., at the beginning
of the dark cycle each day. For animals in the "diabetic"
condition the insulin injections on both the day before
uptake and the one scheduled a few hours before the uptake
were omitted. The omission of this second injection was
necessary to avoid reversing the diabetic state caused by
the preceding 24 hour lack of insulin. This schedule also
approximated the procedure used by Denari and Rosner (19?2).
3Part 1. Forty jaCi H-estradiol was injected 2 hours
before sacrifice to determine the whole homogenate and
nuclear pellet uptake of estradiol.
3
Part 2. One hundred /iCi ^H-estradiol was injected
6 hours before sacrifice to determine estradiol uptake
after a longer in vivo exposure.
Results of Experiment 4
Results of Part 1. A total of 17 animals were used
in this part of the experiment; 8 animals in the diabetic
condition and 9 animals in the nondiabetic condition. One
pituitary sample from an animal in the diabetic condition
was lost and, therefore, could not be used in the analysis
of that tissue
The results of Part 1 are shown in Figure 9 . Two
hours after the injection of ^H-estradiol the plasma
level of radioactivity (measured as DPM/ml) was 4-8$ lower
in the non-diabetic condition than in the diabetic con-
dition, t (15) = 3.84-6, £< 0.01 (top of Figure 16).
The DPM/pg protein varied greatly among the different
tissues; note the scale indication to the left of each
pair of bars for each tissue. In the whole homogenates
(WH) of each of the tissues there was no reliable affect
of diabetic condition. In the nuclear pellet (NP),
however, there was a significant suppression of uptake in:
the hypothalamus (Hth), t (15) = 2.396, 2 -<0.05; the
preoptic area (POA), t (15) = 2.865, 2 <1 0.02; and in the
pituitary (Pit), t (15) = 3.081, 2 ^ 0.01. The slight
suppression of uptake which was observed in the cortical
(Ctx) nuclear pellet was not significant, t (15) = 1.634-,
2 >0.10 (Figure 9).
The bottom of Figure 9 illustrates the NP to WH
ratio. This measure is derived from the same data used
to generate the WH and NP bar graphs just above it and
is indicative of the amount of estradiol which has been
translocated into the nuclei of each tissue relative to
the amount of estradiol in the whole homogenate. This
measure is shown on the same scale for each, tissue, but
there is still a notable variance among the different
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tissues. The NP/WH ratio in the diabetic condition showed
a significant decrease for each of the following tissues:
hypothalamus, t (15) = 3.823, £< 0.002; preoptic area,
t (15) = 3.094, £<.0.01; and pituitary, t (14) = 4.087,
£<0.002; and no reliable effect in the cortex, t (15) =
1.878, £ > 0.05.
Results of Part 2. In this part of the experiment
10 animals were used; 4 in the diabetic condition and 6
in the non-diabetic condition. The results of Part 2 are
summarized in Figure 10.
When animals were sacrificed six hours after the
3infection of H-estradiol there was much less radioactivity
in all tissues than when sacrificed after two hours, de-
3
spite the use of 2.5 fold more H-estradiol (compare the
scales used on Figures 9 and 10). Under these conditions
there were no significant differences between the diabetic
and the non-diabetic conditions in either the whole homo-
genate or the nuclear pellet fractions of any of the tissues
examined.
The plasma radioactivity was essentially the same in
the two groups of animals and the maximum suppression of
NP/WH ratio (in pituitary tissue) was not statistically
significant, t (8) = 1.912, £>*0.05.
Discussion of Experiment 4
In this experiment the effect of diabetic condition
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3on the uptake of H-estradiol was investigated in three
neural tissues and the pituitary gland. The pattern of
results obtained indicates that the withdrawal of insulin
injections from streptozotocin-diabetic animals signifi-
cantly suppresses the concentration of ^H-estradiol in
the nuclear pellet fraction of several tissues two hours
after injection but has no effect six hours after inject-
ion. The suppression of uptake was found, in the pituitary
gland, the hypothalamus and the preoptic area, but not in
the cerebral cortex.
Denari and Rosner (1972) reported that diabetes in-
3hibited the uptake of H-estradiol in NaOH-digested hypo-
thalamic and anterior pituitary tissue. This tissue
preparation can be considered equivalent to the whole
homogenate in the present experiment. Since no effect
of insulin withdrawal was observed on whole homogenate
uptake, the findings of Denari and Rosner (1972) were not
confirmed. One possible reason for this discrepancy may
be that while Denari and Rosner (1972) measured uptake one
hour after the administration of labelled estradiol the
shortest delay used in the present experiment was two
hours.
The results in Part 1 showing suppressed nuclear up-
take of ^H-estradiol but no effect on whole homogenate
uptake as the result of diabetes (note also the NP/WH
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ratios in Figure 9) is indicative of reduced receptor
translocation, rather than a decreased affinity of the
receptor for estradiol or a decreased number of receptors.
This latter point is further supported by a recent pilot
study (Wade, unpublished observations) which indicated
that there was no decrease in the concentration of
cytosol estrogen receptors in the hypothalamic tissue of
ovariectomized, diabetic animals.
The deficit in nuclear uptake of radioactivity at
two hours (Part 1) was not seen when the animals were
sacrificed sixhours after the administration of labelled
estradiol (Part 2). This is interpreted to mean that
the effect of diabetes is to retard, but not to completely
block the rate of receptor-estradiol complex translocation
into the nucleus.
It is not known how the lack of insulin could slow
the rate of nuclear translocation. One possibility is
that the lack of insulin depletes the energy stores of
the particular cells which concentrate estradiol, and
this lowered energy reserve adversely affects the rate
of nuclear translocation. Another possibility is that the
effect is secondary to some other effect of acute insulin
withdrawal such as hyperglycemia or hyperlipidemia.
The unusually high radioactivity levels in the plasma
of diabetic animals (top of Figure l) cannot account for
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the decreased neural and hypophyseal uptake of H-estradiol
(by, for example, "pulling" estradiol away from these
tissues); because there is no deficit in the whole homo-
genate uptake.
General discussion of Section II
In Experiment 3 it was found that diabetes significant-
ly reduced the facilitation of sexual receptivity by estra-
diol benzoate and in Experiment 4 it was ffiund that dia-
betes ratarded the translocation of estradiol into the
cell nuclei of the hypothalamus, preoptic area and pit-
uitary. It seems likely, but difficult to prove, that
the suppression in the behavioral effects of EB are a
result of the demonstrated retardation in nuclear uptake
of estradiol. Although the conditioning period for the
stimulation of receptivity by estradiol requires at least
17 hours (Green et al. , 1970) the first few hours are
probably critically improtant. This is likely to be
particularly true when the dose of estradiol benzoate is
very close to threshold.
Other reasons for the behavioral deficit cannot be
ruled out, however. Perhaps, for example, the lack of
insulin also reduces the ability of some neural cells to
produce a particular protein or neurotransmitter which is
necessary for the display of sexual receptivity.
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SECTION III
THE EFFECT OF THYROID HORMONES ON
ESTRADIOL STIMULATED SEXUAL RECEPTIVITY
Thyroid hormone is known to interact with hypophyseal-
gonadal function. Hyperthyroidism induces prolonged di-
estrus and hypothyroidism induces prolonged estrus in
female rats (Van Horn, 1935 )* Although there is some evi-
dence that thyroid hormones have a direct effect on
gonadotropin release (in ovariectomized rats, La Rochele
& Freeman, 1974 ) the weight of the available findings
suggests that the effect in intact females is the result
of either changes in estrogen metabolism which accompany
changes in thyroid hormones or the altered response
of ovarian tissue to gonadotropins. In ovariectomized
rats thyroxine-treatment suppresses and thyroidectomy
facilitates LH and FSH release (La Rochele & Freeman,
1974 ), but in hyperthyroid women LH levels are higher
than normal after exogenous estrogen treatment (Akande
& Hockaday, 1972
,
cited in La Rochele & Freeman, 1974 )
and in thyroidectomized or propylthiouracil (PTU)-
treated rats hemicastration-induced compensatory hyper-
trophy is suppressed (Florsheim, Rudko, Corcorran &
Bodfish, 1967 ; Saiduddin, 1972 ) suggesting LH levels are
lower than normal. Thus in gonadally intact females hyper-
thyroidism appears to cause hyposensitivity to the neg-
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ative feedback effect of endogenous estrogens, while hypo-
thyroidism appears to cause hypersensitivity.
These effects can be explained by the findings that
there is decreased ovarian steroid catabolism in hypo-
thyroid rats (Rail, Robbins & Lewallen, 1964; Tait & Bur-
stein, 1964). Gallagher et al. (1966) have reported that
while estradiol and estrone are in equilibrium (favoring
estrone), estrone is competitively metabolized to either
estriol or the catechol estrogen 2-OH-estrone, which is
further metabolized to 2-methoxyestronej and the direction
in which estrone is metabolized is influenced by thyroid
hormones. In hyperthyroid individuals there is an increase
in 2-hydroxy- and 2-methoxy-estrone, while in myxedema
(hypothyroidism) there is an increase in estriol. Thus
given the fact that estriol is, and 2-hydroxy- and 2-methoxy-
estrone are not effective estrogens on most physiological
measures including sexual receptivity it is suggested
that the systemic availability of estrogenic metabolites
of estradiol can be reduced by thyroid function.
Consistent with this hypothesis Ruh, Ruh and Klitgaard
(1970) found that the uterine whole homogenate concentra-
tion of in vivo injected ^H-estradiol was significantly
increased by thyroidectomy when measured 6, 10 or 16 (but
not 1) hour after injection. Seven days of thyroxine
treatment (100 pg/kg body weight/day) tended to suppress
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^H-estradiol uptake at 6, 10 and 16 hours postinjection
but the effect was not statistically significant.
Cidlowski and Muldoon (1975) determined cytosol
estrophile concentrations by in vitro incubation with
3H-estradiol using uterine, hypothalamic and anterior pitu-
itary tissues of thyroidectomized, thyroxine treated or
control female rats. They found no changes in receptors
of hypothalamus, but they did find that thyroxine treatment
decreased and thyroidectomy increased cytosol receptors
in uterine tissue of gonadally-intact animals.
Thyroxine is the only nonsteroid hormone which is
known to have an intracellular receptor which is
translocated into the cell nucleus. It is relevant
therefore that Cidlowski and Muldoon (1975) also reported
that thyroxine does not compete for the estrogen receptors.
Thus it can he concluded that the increase in estradiol
uptake in hypothyroid animals, and the tendency toward
decreased uptake in hyperthyroid animals reported by
Rub et al. (1970) is not the result of competitive binding.
Experiment 5
Effects of Thyroid Hormones on Sexual Behavior
Relative decrements of reproductive behavior and
fertility have been associated with both hypo- and hyper-
thyroidism in several species (see Young, 1961, for a
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review). In noncastrated animals these effects can be
considered secondary to the known effects of thyroid
hormones on gonadotropin secretion. The only published
study using ovariectomized animals was done with long-
term (30 days) thyroidectomized guinea pigs (Hoar, Gov &
Young, 1957). After infections of EB and progesterone,
thyroidectomized animals showed a significant decrement
in sexual receptivity compared with controls. These
animals also showed reduced sexual activity during the
period between thyroidectomy and ovariectomy, and it is
possible that the reduced sexual activity in response
to EB and progesterone was the result of either unequal
conditioning before ovariectomy or the generalized
depressed metabolic state of long-term thyroidectomized
animals.
Another estrogen-sensitive behavior in rats which
has been examined in relation to thyroid function is
wheel running activity. Stern ( 1970 ; Stern & Murphy, 1972 )
found that EB infections to ovariectomized rats could stim-
ulate wheel running in both hypo- and hyperthyroid animals.
A comparison of the two studies reveals that 1 pg EB/day
was at least as effective in hypothyroid animals as 15
pg EB/day in hyperthyroid animals suggesting the possibility
that the behavioral sensitivity to estradiol is increased
in the absence of thyroid hormones.
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In the present experiments sexual behavior was tested
in EB and progesterone-primed ovariectomized rats before
and after short-term administration of PTU or thyroxine
(T^). Short-term PTU and T^ administration was used to
avoid dramatic differences in mean body weight between
groups.
Method
Thirty female rats (CD strain, purchased from Charles
River Breeding Laboratories) were ovariectomized by the
same procedure as described in Experiment 1. One animal
died in surgery and the remaining 29 animals were used
in all parts of the experiment. Animals were housed in
individual cages in an air conditioned room with a 12:12
light: dark cycle and were fed Purina Laboratory Chow ad
libitum .
Sexual receptivity was determined, by the same method
as described for Experiment 3. To bring the animals into
heat 2 or 4 pg EB/kg body weight was injected 54 hours
before testing and 0.5 mg progesterone was injected 6
hours before testing. All steroid hormone injections were
given subcutaneously in the back of the neck. Each
behavioral testing period was separated by one week.
Testing sessions began approximately two hours after
the beginning of the dark cycle. Scoring was done
"blind" as to which treatment each animal had received.
50
After ovariectomy and before beginning propylthio-
uracil and thyroxine treatments each animal was tested
with both doses of EB. The results of this test served
as a baseline to compare the change in mean lordosis
rating for each testing procedure and as a "screening"
to insure that every animal displayed some measurable
receptivity. The scores on the screening test were also
used to assign each animal to one of three groups matched
for mean MLR.
One group of animals (N = 10) was made hypothyroid
by giving them PTU (0.04$, dissolved in tap water at
pH 8.5) in their drinking water. A second group of
animals (N = 10) was made hyperthyroid by daily intraper-
itoneal injections of L-thyroxine (25 pig, dissolved in
saline at pH 11.5). The third group of animals (N = 9)
served as controls and received daily intraperitoneal in-
jections of saline (at pH 11.5)
•
Body weight was measured each week just before EB
injections and water intake was recorded daily for all
animals receiving PTU and for six animals in the control
group
.
Method for Part 1. One day after the initiation of
PTU and thyroxine half of the animals in each group were
given 2 pg EB/kg while the other half were given 4- ng/kg
EB. All animals were tested 54- tours later (on Day 5 of
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treatment). Seven days later this same procedure was
repeated with each animal receiving the same dose of EB.
Method for Fart 2. Because no facilitation of
receptivity was observed in the results of Part 1, on
the third testing session (Day 17 of treatment) all animals
were tested with the high dose of EB (4- ;ig/kg).
Besults of Experiment 5
The data for one animal in the thyroxine-treated,
high-EB dose group were eliminated from the analysis
because this animal always held a low, crouched posture
never allowing males the opportunity to make a good
mount.
The body weight gain of PTU-treated animals between
baseline and Day 10 of treatment was 6 g in contrast to
21 g for controls, t (17) = 5*624, 2 ^ 0.01. The mean
daily water intake was also about 65$ that of controls.
The results of behavioral testing 3, 10 and 17 days
after beginning PTU and thyroxine are summarized in Figure
11. All three groups showed a general decrease in recep-
tivity over the testing periods. There was no effect of
either PTU or thyroxine treatment on either Day 3 or Day
10. On Day 17 the decrease in the PTU-treated animals was
essentially the same as the decrease in controls, Fisher
Exact Probability, 2 * 0.40. The suppression of receptivity
in thyroxine treated animals, however, was significantly
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more common than in control animals, Fisher Exact Probab-
ility, £ 0 . 05 .
Discussion of Experiment 5
This experiment was intended to test the effect
of hyper- and hypothyroidism on estradiol-stimulated
sexual receptivity in female rats. The attempted
induction of hypothyroidism clearly had no effect
on sexual receptivity. Since thyroidectomy has been
found to affect sexualreceptivity in guinea pigs (Hoar
et al.
, 1957) the most likely explanation for the
present results is simply that the animals were not
hypothyroid. Although suppressed weight gain was
observed in these animals and is usually indicative
of hypothyroidism, it is possible that the decreased
weight gain observed in this case was secondary to the
decrease in water intake.
The suppression of sexual receptivity by thyroxine
treatment was significant after 17 days of treatment.
The reason for this effect remains unclear. However,
one possibility is that the thyroxine alters the
metabolism of estradiol toward less estrogenic or
possibly antiestrogenic compounds, i.e., the catechol
estrogens (Gallagher et al. . 1966).
The estradiol metabolite which is decreased in
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hyperthyroid states is estriol (Gallagher et al.
, 1966).
This hormone must be given in a dose four-fold that of
estradiol to produce equivalent sexual receptivity in
female rats when administered in daily injections
(Beyer, Morali and Vargas, 1971). Daily injections,
however, producing pulses of estriol, do not mimic the
slow continuous conversion of estradiol to estriol and
this may have led to an underestimation of the behavior-
al potency of estriol. This possibility is suggested
by the recent results of Clark, Paszko and Peck (1977)
on the uterotrophic effects of estriol. These investi-
gators have found that whereas estriol is a weak utero-
trophic agent when administered in daily injections it
is equivalent to estradiol when administered via paraffin
pellets.
The behavioral effect of estriol administered slowly
is unknown and until a significant agonistic effect of
estriol (or antagonistic effect of catechol estrogens)
can be confirmed, the hypothesis that thyroxine decreases
the behavioral response to estradiol by an alteration
of its metabolism remains incompletely tested.
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